| Metformin derived carbon dots: Highly biocompatible fluorescent nanomaterials as mitochondrial targeting and blood-brain barrier penetrating biomarkers EK Cilingir, ES Seven, Y Zhou, BM Walters, KJ Mintz, RR Pandey, ... Journal of colloid and interface science 592, 485-497, 2021 | 53 | 2021 |
| Crossing the blood–brain barrier with carbon dots: uptake mechanism and in vivo cargo delivery ES Seven, YB Seven, Y Zhou, S Poudel-Sharma, JJ Diaz-Rucco, ... Nanoscale advances 3 (13), 3942-3953, 2021 | 39 | 2021 |
| Gel-like carbon dots: A high-performance future photocatalyst Y Zhou, AE ElMetwally, J Chen, W Shi, EK Cilingir, B Walters, KJ Mintz, ... Journal of colloid and interface science 599, 519-532, 2021 | 24 | 2021 |
| pH and redox triggered doxorubicin release from covalently linked carbon dots conjugates SD Hettiarachchi, EK Cilingir, H Maklouf, ES Seven, S Paudyal, S Vanni, ... Nanoscale 13 (10), 5507-5518, 2021 | 24 | 2021 |
| Structure-activity relationship of carbon nitride dots in inhibiting Tau aggregation Y Zhou, N Kandel, M Bartoli, LF Serafim, AE ElMetwally, SM Falkenberg, ... Carbon 193, 1-16, 2022 | 23 | 2022 |
| Hydrothermal vs microwave nanoarchitechtonics of carbon dots significantly affects the structure, physicochemical properties, and anti-cancer activity against a specific … ES Seven, EK Cilingir, M Bartoli, Y Zhou, R Sampson, W Shi, Z Peng, ... Journal of colloid and interface science 630, 306-321, 2023 | 16 | 2023 |
| Nano-carrier for gene delivery and bioimaging based on pentaetheylenehexamine modified carbon dots W Zhang, J Chen, J Gu, M Bartoli, JB Domena, Y Zhou, BCLB Ferreira, ... Journal of colloid and interface science 639, 180-192, 2023 | 15 | 2023 |
| Development of red-emissive carbon dots for bioimaging through a building block approach: fundamental and applied studies KJ Mintz, EK Cilingir, G Nagaro, S Paudyal, Y Zhou, D Khadka, S Huang, ... Bioconjugate chemistry 33 (1), 226-237, 2021 | 15 | 2021 |
| Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: advances in extended and targeted drug delivery B Abdi, M Mofidfar, F Hassanpour, EK Cilingir, SK Kalajahi, PH Milani, ... International journal of pharmaceutics 638, 122740, 2023 | 9 | 2023 |
| Chalcones as anti-glioblastoma stem cell agent alone or as nanoparticle formulation using carbon dots as nanocarrier EA Veliz, A Kaplina, SD Hettiarachchi, AL Yoham, C Matta, S Safar, ... Pharmaceutics 14 (7), 1465, 2022 | 8 | 2022 |
| Surface modification of carbon nitride dots by nanoarchitectonics for better drug loading and higher cancer selectivity EK Cilingir, M Sankaran, JM Garber, FA Vallejo, M Bartoli, A Tagliaferro, ... Nanoscale 14 (27), 9686-9701, 2022 | 8 | 2022 |
| DFMO carbon dots for treatment of neuroblastoma and bioimaging S Paudyal, FA Vallejo, EK Cilingir, Y Zhou, KJ Mintz, Y Pressman, J Gu, ... ACS applied bio materials 5 (7), 3300-3309, 2022 | 6 | 2022 |
| Advancing glioblastoma imaging: Exploring the potential of organic fluorophore-based red emissive carbon dots JB Domena, BCLB Ferreira, EK Cilingir, Y Zhou, J Chen, QR Johnson, ... Journal of colloid and interface science 650, 1619-1637, 2023 | 5 | 2023 |
| An insight into embryogenesis interruption by carbon nitride dots: can they be nucleobase analogs? Y Zhou, J Chen, EK Cilingir, W Zhang, L Gonzalez, S Perez, A Davila, ... Nanoscale 14 (47), 17607-17624, 2022 | 3 | 2022 |
| Cell-nucleus Targeted Peptide Tethered Quadruple Carbon Dots for Treatment of High-grade Gliomas EK Cilingir, SD Hettiarachchi, Y Zhou, BCLB Ferreira, S Vanni, ... | 2 | 2022 |
| Small Warriors of Nature: Novel Red Emissive Chlorophyllin Carbon Dots Harnessing Fenton‐Fueled Ferroptosis for In Vitro and In Vivo Cancer Treatment E Kirbas Cilingir, O Besbinar, L Giro, M Bartoli, JL Hueso, KJ Mintz, ... Small, 2309283, 2024 | | 2024 |
| Nanoarchitectonics of Carbon Dots: A Study of the Multifunctional Chemical Toolbox for Improved Drug Delivery and Bioimaging Systems EK Cilingir University of Miami, 0 | | |
| Carbon Dot Nanoarchitectonics: Quadruple Conjugated Nano Model for Superior Cancer Cell-Nucleus Targeting and Multi Drug Delivery RM Graham, E Kirbas Cilingir, SD Hettiarachchi, Y Zhou, BCLB Ferreira, ... Available at SSRN 4151704, 0 | | |
Yiqun ZhouRocheVerified email at roche.com
